28

CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,
Page 2: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

CORPORATE REVIEW OF «OTIPHARM» COMPANY

Vision, mission, values, advantages, opportunities ...

Page 3: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

OtiPharm Research =

Objective Trials in Pharma

Page 4: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

MISSIONWe create regulatory products for the head of regulatory affairs department (the Regulatory Director / Development Director / CEO) using the expert conclusion of qualified specialists of pharmaceutical industry.

Our team is represented by qualified scientists and clinicians (GCP certification, PhD certification)

Managing the life cycle of a medicine is our core competence.

Page 5: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

OtiPharm Values

clients: - reliable partners - partnership at all levels staff: - talent disclosure - education - one team

INTER-STRENGTHENING

- engagement of highly qualified specialists

- scientific substantiation of documentation

- objectivization of expert conclusions - realism and predictability

EXPERITY

- only legal methods of work

- confidentiality - team responsibility - security of information - control of regulatory

deadlines

SAFETY

- IT products for «Big Data» - the digitalization of information - plan to use artificial intelligence - systematization and

optimization of data management

INNOVATION

Page 6: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

The support of regulatory procedures

The implementation of IT-technologies in pharm. companies practice

The safety of medicines treatment

Developing access of pharm. companies to the foreign markets

STRATEGIC WAYS OF OtiPharm Rеsearch company:

Page 7: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Digital databases services

Regulatory procedures

support

Pharmacovigilance base installation

Maintaining and updating the pharmacovigilance base

Regulatory base implementation

Regulatory system audit

Development and support of regulatory documentation

Advisory services for settlement of dispute situations

Recommendations for the life cycle of products

STRATEGIC WAYS OF OtiPharm

Page 8: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

The support of approval of GMP requirements for manufactures

Bringing the registration materials in compliance with government regulations

Cooperation with international partners

Promoting access to

international markets

Pharmacovigilance system audit

Development and renovation of documentation

QPPV services

PV trainings

Drug safety issues

STRATEGIC WAYS OF OtiPharm

Page 9: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

IT-PLATFORM

QPPV

REPORTS

SUPPORT

NEW MOLECULES

03

0105

0204

OUR SERVICES

Page 10: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

"Fresh view" of our company experts will help you to identify "hot spots" in regulatory practice of your company.

1. Regulatory procedures support

Regulatory system audit conducting a preliminary assessment of the state of regulatory system:

• compliance with the requirements of GMP • the quality and completeness of the registration materials

providing recommendations on bringing your company's materials up to the actual requirements of the current legislation

development of proposals for solving possible problems

Page 11: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Scientific and methodological implementation of proper regulatory practice:

development, updating and actualization of registration dossier sections

compiling of master files, SOPs, job instructions and training of personnel involved in ensuring the quality and safety of drugs

advisory services of independent experts

generation of decisions in process of registration that meet current industry standards and legal requirements

use of the latest scientific research and international industry experience in the field of new molecules of medicines development, as well as ways to deliver them in registration procedures

1. Regulatory procedures support

Page 12: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Regardless of whether you need help in daily regulatory activities, or just competent expert advice, we can meet your needs.

Registration and re-registration of medicines, supplements, medical products and making changes in normative and technical documentation

Licensing of manufacturers and distributors of medical products

Regulatory procedures services

1. Regulatory procedures support

Page 13: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Experts and translators services:

1. Regulatory procedures support

Organization and implementation of additional laboratory, experimental and clinical studies, needed during the procedure:

- Base selection - Development of a draft protocol - Optimize research budget - Scientific and methodological support

- Development of the dossier necessary sections - Preparation of scientifically substantiated argument for comments of experts of the regulatory body - Professional translation into the state language

Clinical trials

Page 14: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

1. Regulatory procedures support

Registration of biologically active products, cosmetics and medical products

- Submission of applications, questionnaires and dossiers to registration organizations (State Medical Enterprise "Ukrainian Medical Certification Center»)

- Technical documentation preparation (product characteristics, control methods, draft instructions for use and marking, etc.)

- Development of a technical dossier (technical characteristics of the medicine) in accordance with regulatory requirements and existing certificates (ISO 9001, 13485, CE (Directives 93/42 / EEC and 90/385 / EEC, etc.) and documentation on the quality management system

Page 15: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

2. The safety of medicines treatment

Establishment and support of the continuous functioning of the pharmacovigilance system

Active monitoring of adverse reactions and lack of product efficacy

Qualified response to "hot signals" and controversial situations

Preparation of documents for registration procedures (RMP, ACO)

Page 16: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Establishment and maintenance of the continuous functioning of the pharmacovigilance system of the applicant, manufacturer and supplier of

pharmaceutical products

Assessment of quality of pharmacovigilance and MF, pre-audit

Development of the MF, SOPs of the pharmacovigilance system and / or bringing them into compliance with the requirements of current legislation.

Conclusion of functional responsibilities for officials involved in the pharmacovigilance of company

Trainings for company staff

Implementation of 7x24 system

Our team employs qualified specialists who have experience in establishing and maintaining the functioning of the PV system

2. The safety of medicines treatment

Page 17: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Qualified response to "hot signals" and controversial situations

• Validation of reports about detection of adverse reactions

• Assistance in appealing during a full or temporary prohibition of the circulation of a medicinal product

• Accompanying the procedure for renewal of the medical product on the market

Active monitoring of adverse reactions and lack of product efficacy

• Systematic search and analysis of world medical literature and information from recognized regulators (FDA, MHRS, etc.) about the fact of the findings of side effects or ineffectiveness of medicinal products

2. The safety of medicines treatment

Page 18: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

1. Regulatory procedures support

Materials from the pharmacovigilance section required in the various regulatory procedures

- registration, re-registration of medicines - change of applicant / manufacturer of

products or authorized person of pharmacovigilance section

- Risk Management Plan (RMP), - Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes

(Addendum to clinical overview, ACO)

- New development - Actualization according to updated data - Preparing responses to remarks of regulatory

bodies

Clinical trials

Company experts can provide assistance, based on customer documents in the form of:

Page 19: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

The database is used for pharmacovigilance and regulatory procedures

The database is certified and validated by the Institute of software systems of National Academy of Sciences of UkraineThe database can be in three

languages - Ukrainian, Russian and English

3.Digital Database:Providing services to its clients, OtiPharm Research uses a modern high-tech certified IT Database included in the national notification system of side effects detection while using medicinal products.

Page 20: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

3. Digital database

meet industry standards and legislative requirements

Services of conducting digital database

adapt to the interests and specific wishes of clients

allow testing in trial mode

Advantages:

Page 21: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

✓ Monitoring of the registration procedures and prompt reaction to regulatory remarks

4. Assistance in medicines export to foreign markets, the CIS, countries of the Asia-Pacific region and Africa:

✓ Complying the registration dossier with the specific requirements of the state legislation

✓ Promoting the co-operation of international manufacturers and distributors of medical products

Our specialists have significant experience of cooperation with international regulatory agencies

Page 22: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

«OTIPHARM»Advantages

We create an atmosphere of trust and motivation in cooperation with our partners

Flexibility in tasks performing

Customer orientation:

We provide regulatory services in the field of medicines, vaccines and medical products circulation according to customer wishes

Observance of terms in the agreements execution

The steady increase in number of customers

Reliable business partners

Providing services

according to specific

requirements of clients

Qualified and educated

experts

Constant perfection in

accordance with the needs of today

Page 23: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Emergence in provision of services (1+1>2): ✓ A highly qualified team of our company experts with

practical experience of work in expert and regulatory bodies, which can provide comprehensive professional consultations on wide range of issues concerning the organization of processes of medicines production, control of quality and safety of use.

Stable and legal methods ✓ Help pharm. companies to achieve a reliable result in

due time

«OTIPHARM»Advantages

The steady increase in number of customers

Reliable business partners

Providing services

according to specific

requirements of clients

Qualified and educated

experts

Constant perfection in

accordance with the needs of today

Page 24: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

An Expert Institute in the Company's System of Work

Highly qualified experts with experience since the creation of regulatory bodies in independent Ukraine have the competence for:

• Conducting scientific research

• Examination of registration documents and providing conclusions about quality, preclinical and clinic

• Organization of professional trainings, seminars, round tables and conferences on topical issues of pharmaceutical industry

Page 25: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

We will protect your interests if they are substantiated by objective scientific and methodological arguments

Managing the life cycle of a medicine

a search of promising molecules and methods of their delivery for manufacturers of medicines and dietary supplements

preparation of registration materials at Ukrainian and European scientific bases

updating of methodical basis of the medicine based on the monitoring of scientific literature

conducting experimental and clinical studies to establish (confirm) new data

including up-to-date data to the registration file and regulatory documents

Page 26: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Customers list database✓ Yuria-Pharm, Ukraine

✓ Kusum Pharm, Ukraine-India

✓ Mili Healthcare Ltd., Great Britain

✓ Olfa, Ukraine

✓ Olainfarm, Latvia

✓ Lekhim, Ukraine

✓ Acino Pharma Start, Switzerland

✓ Fitofarm, Ukraine

✓ Interpharmbioteck, Ukraine

✓ Biopharma, Ukraine

✓ Gledpharmn Ukraine

✓ Bioscience, Ukraine

✓ Sperco, Ukraine-Spain We will protect your interests if they are substantiated by objective scientific and methodological arguments

Page 27: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

✓ Sandoz, Switzerland

✓ Bioton, Poland

✓ Esparma, Germany

✓ Peptigroupe Inc., Canada

✓ Zdorovye, Ukraine

✓ Kyiv Vitamin Factory, Ukraine

✓ GNCLS, Ukraine

✓ Eurolifecare, Great Britain

✓ Sperco, Ukraine-Spain

✓ RIC-pharm, Ukraine

✓ Propharma, Ukraine

We will protect your interests if they are substantiated by objective scientific and methodological arguments

Customers list regulatory

Page 28: CORPORATE REVIEW OFotipharm.com/wp-content/uploads/2020/04/otipharm...- Updated (regular) safety reports (PSURs); - Clinical overviews and its appendixes (Addendum to clinical overview,

Contact Us

+380 67 568 68 96

www.otipharm.com

[email protected]

facebook.com/OtiPharm

linkedin.com/company/otipharm